NEW YORK, Aug. 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Celsion Corporation (NASDAQ:CLSN), Alpha and Omega Semiconductor Limited (NASDAQ:AOSL), SP Plus Corporation (NASDAQ:SP), Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), La Jolla Pharmaceutical Company (NASDAQ:LJPC), and SPX Corporation (NYSE:SPXC), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
CLSN DOWNLOAD: http://Fundamental-Markets.com/register/?so=CLSN
AOSL DOWNLOAD: http://Fundamental-Markets.com/register/?so=AOSL
SP DOWNLOAD: http://Fundamental-Markets.com/register/?so=SP
MACK DOWNLOAD: http://Fundamental-Markets.com/register/?so=MACK
LJPC DOWNLOAD: http://Fundamental-Markets.com/register/?so=LJPC
SPXC DOWNLOAD: http://Fundamental-Markets.com/register/?so=SPXC
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Celsion Corporation (NASDAQ:CLSN), Alpha and Omega Semiconductor Limited (NASDAQ:AOSL), SP Plus Corporation (NASDAQ:SP), Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), La Jolla Pharmaceutical Company (NASDAQ:LJPC), and SPX Corporation (NYSE:SPXC) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 14th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
CELSION CORPORATION (CLSN) REPORT OVERVIEW
Celsion's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Celsion reported revenue of $0.13MM vs $0.13MM (unchanged) and basic earnings per share -$0.25 vs -$3.09. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Celsion reported revenue of $0.50MM vs $0.50MM (unchanged) and basic earnings per share -$2.72 vs -$11.89. Celsion is expected to report earnings on November 13th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.39. The estimated EPS forecast for the next fiscal year is -$1.23 and is expected to report on March 26th, 2019.
To read the full Celsion Corporation (CLSN) report, download it here: http://Fundamental-Markets.com/register/?so=CLSN
-----------------------------------------
ALPHA AND OMEGA SEMICONDUCTOR LIMITED (AOSL) REPORT OVERVIEW
Alpha and Omega Semiconductor's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Alpha and Omega Semiconductor reported revenue of $102.90MM vs $93.28MM (up 10.31%) and basic earnings per share $0.07 vs $0.15 (down 53.33%). For the twelve months ended June 30th, 2017 vs June 30th, 2016, Alpha and Omega Semiconductor reported revenue of $383.34MM vs $335.66MM (up 14.20%) and basic earnings per share $0.59 vs -$0.13. Alpha and Omega Semiconductor is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.19. The estimated EPS forecast for the next fiscal year is $0.93 and is expected to report on August 14th, 2019.
To read the full Alpha and Omega Semiconductor Limited (AOSL) report, download it here: http://Fundamental-Markets.com/register/?so=AOSL
-----------------------------------------
SP PLUS CORPORATION (SP) REPORT OVERVIEW
SP Plus' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, SP Plus reported revenue of $362.20MM vs $403.50MM (down 10.24%) and basic earnings per share $0.68 vs $0.73 (down 6.85%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, SP Plus reported revenue of $1,590.50MM vs $1,568.40MM (up 1.41%) and basic earnings per share $1.86 vs $1.04 (up 78.85%). SP Plus is expected to report earnings on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.50. The estimated EPS forecast for the next fiscal year is $2.41 and is expected to report on February 20th, 2019.
To read the full SP Plus Corporation (SP) report, download it here: http://Fundamental-Markets.com/register/?so=SP
-----------------------------------------
MERRIMACK PHARMACEUTICALS, INC. (MACK) REPORT OVERVIEW
Merrimack Pharmaceuticals' Recent Financial Performance
Merrimack Pharmaceuticals is expected to report earnings on November 14th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.40. The estimated EPS forecast for the next fiscal year is -$3.92 and is expected to report on March 11th, 2019.
To read the full Merrimack Pharmaceuticals, Inc. (MACK) report, download it here: http://Fundamental-Markets.com/register/?so=MACK
-----------------------------------------
LA JOLLA PHARMACEUTICAL COMPANY (LJPC) REPORT OVERVIEW
La Jolla Pharmaceutical's Recent Financial Performance
La Jolla Pharmaceutical is expected to report earnings on October 25th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$1.19. The estimated EPS forecast for the next fiscal year is -$4.67 and is expected to report on February 28th, 2019.
To read the full La Jolla Pharmaceutical Company (LJPC) report, download it here: http://Fundamental-Markets.com/register/?so=LJPC
-----------------------------------------
SPX CORPORATION (SPXC) REPORT OVERVIEW
SPX's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, SPX reported revenue of $379.20MM vs $349.70MM (up 8.44%) and basic earnings per share $0.54 vs -$0.21. For the twelve months ended December 31st, 2017 vs December 31st, 2016, SPX reported revenue of $1,425.80MM vs $1,472.30MM (down 3.16%) and basic earnings per share $2.11 vs -$2.05. SPX is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.36. The estimated EPS forecast for the next fiscal year is $2.65 and is expected to report on February 21st, 2019.
To read the full SPX Corporation (SPXC) report, download it here: http://Fundamental-Markets.com/register/?so=SPXC
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.